Sitemap
Expand All
- Home
- This is Bayer
- Innovation
- Product Areas
-
Media
- The latest news
-
News
- 2020
-
2019
- Bayer increases sales and earnings – leader in agriculture after acquisition
- Bayer: strong operational start to the year
- Bayer on track in operational business
- Bayer to sell its Animal Health business unit to Elanco for 7.6 billion U.S. dollars
- Bayer: Encouraging business performance across all divisions
- バイエル、理科実験教室「わくわく実験びっくり箱」を12月10日に鳥取で初開催 鳥取特産の「とうふちくわ」や「らっきょう」など身近な素材で実験
- バイエル、動物用薬品事業部をエランコに76億ドルで売却
- 『理科っ子になる夏！ バイエル サイエンス・ファーム』開催 初日は約1,100名が来場、DNA抽出実験や動物のお医者さんを体験
-
2018
- Bayer: Conditions for beginning Monsanto integration fulfilled
- LEO Pharma to expand its lead in medical dermatology with acquisition of Bayer’s prescription dermatology unit
- Bayer closes Monsanto acquisition
- Bayer plans closing of Monsanto acquisition on June 7
- U. S. Department of Justice conditionally approves Bayer’s proposed acquisition of Monsanto
- Bayer: Operational business held back by currency effects － Major progress with Monsanto acquisition
- Bayer signs agreement to sell further Crop Science businesses to BASF for up to 1.7 billion euros
- European Commission conditionally approves Bayer’s proposed acquisition of Monsanto
- Bayer: business at prior-year level － on track with strategy
- Bayer completes biggest acquisition in its history
- Bayer: Good performance in a challenging environment, Group outlook confirmed
- Bayer to strengthen core life science businesses while significantly enhancing productivity and profitability
- バイエル、モンサント買収をクローズ
- 体験型学習イベント『理科っ子になる夏！ バイエル サイエンス・ファーム』開催 DNAの抽出実験×どうぶつのお医者さん体験×東大生のサイエンスショーなど
- バイエル ホールディング株式会社 社長交代のお知らせ
- Publications
- Sustainability
- Career